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One of the greatest areas of scientific progress has been the
identification of certain infectious agents that are implicated
in the carcinogenic process. This new knowledge has had
broad repercussions not only in the application of new pri-
mary prevention options, such as prophylactic vaccines, but
also in the definition of infection biomarkers that can be used
as screening alternatives or as prognostic markers for neo-
plasia. We now know that chronic infection with the patho-
genic bacteria Helicobacter pylori (H. pylori) is associated
with gastrointestinal tract disorders, ranging from chronic
gastritis to gastric adenocarcinoma; there is also evidence of
a possible association with gastric lymphoma and peptic
ulcer. Published reports support the existence of geographic
regions where this bacterium is endemic and where H. pylori
colonization occurs at a very early age in populations living
in precarious sanitary conditions. For this reason, gastric
cancer is one of the most common cancers in the world in
low-resource countries and, as noted in the accompanying
articles [1, 2], one with great heterogeneity in terms of
incidence and mortality in Latin America. As a result, this
geographic region constitutes a fascinating setting for
research and provides unique and important opportunities for
gastric cancer prevention.
From a public health perspective, there are currently two
major lines of research and action in regard to H. pylori and
gastric cancer. On the one hand, we should gain a more precise
understanding of the natural history of H. pylori infection
and, as a consequence, learn about the triggering mecha-
nism(s) related to chronic exposure in the development of
gastric adenocarcinoma. However, we also know that reduc-
ing future incidence of gastric cancer is possible by improving
the living conditions of the general population from a hygienic
perspective, as confirmed by Porras et al. [3] in this special
edition. Evidence now exists, which established H. pylori as a
part of normal human microbiota [4]. This line of work indi-
cates that this bacterium has a special tropism for gastric
mucosa, that strains with toxic potential exist, and that the
bacteria secrete proteins such as vacA [5], which produce
vacuolization in cultures of human epithelial cells as well as
increased capacity to modify molecules. Given the existing
evidence from biomedical and epidemiological research
underscoring the high degree of genetic diversity in H. pylori
[6], prevention is arguably very complex.
Research groups in Latin America have generated an
invaluable scientific tradition for generation of new hypoth-
eses [7], evidence for interventions [8], and high-impact
publications [9] related to the study of the carcinogenic pro-
cess in gastroduodenal mucosa. Recently, a Latin American
H. pylori research consortium was formed with the primary
mission of evaluating effectiveness, feasibility, and cost of
eradication using an antimicrobial regimen specifically for
Latin America. Results are encouraging and demonstrate the
technical and academic abilities of the participating groups
[10]. They also indicate that treatment regimens for successful
eradication need to be region-specific; thus, adopting suc-
cessful treatment regimens from high-income countries may
not be the best solution for lower-income countries. Adding to
this line of work, results of a diverse set of research studies
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conducted in various regions of Latin America are presented
in this special issue, which reveal the great heterogeneity
that exists in the region. These publications include topics
such as potential solutions for gastric cancer surveillance in
low-resource countries [11], ecological data in support of the
altitude–gastric cancer association [1], assessment of the
utility of serologic biomarkers for risk of gastric cancer
in three Latin American countries [2], confirmation of risk
factors for H. pylori infection [3], and a meta-analysis of a
variety of risk factors and gastric cancer risk [12].
The work presented in this special edition of the journal
along with the recently formed consortium underscores the
enormous potential that multi-centric regional studies have
for addressing the magnitude of health problems, and even
more important, identify solutions for prevention of future
disease. These invaluable resources allow us to postulate
new research hypotheses and to consolidate a regional
group, which can contribute to improving therapeutic
strategies for prevention and control of gastric cancer and
build the foundation for evidence-based regional public
policies aimed at improve the quality of life of the
population.
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